Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Trial Antimicrobial Resistance April 28, 2014 …
Rutgers Awarded $26M to Lead Development of New Antibiotics Antimicrobial Resistance April 28, 2014 …
Novel Agent for Tamiflu-Resistant pH1N1 Influenza Virus Discovered Medical Countermeasures April 24, 2014 …
Researchers Discover Possible New Target to Attack Flu Virus Medical Countermeasures April 13, 2014 …
